These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. R(+)-8-OH-DPAT, a serotonin(1A) receptor agonist, potentiated S(-)-sulpiride-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens but not striatum. Ichikawa J, Meltzer HY. J Pharmacol Exp Ther; 1999 Dec; 291(3):1227-32. PubMed ID: 10565846 [Abstract] [Full Text] [Related]
3. Contrasting contribution of 5-hydroxytryptamine 1A receptor activation to neurochemical profile of novel antipsychotics: frontocortical dopamine and hippocampal serotonin release in rat brain. Assié MB, Ravailhe V, Faucillon V, Newman-Tancredi A. J Pharmacol Exp Ther; 2005 Oct; 315(1):265-72. PubMed ID: 15987834 [Abstract] [Full Text] [Related]
4. The effect of the selective 5-HT1A agonists alnespirone (S-20499) and 8-OH-DPAT on extracellular 5-hydroxytryptamine in different regions of rat brain. Casanovas JM, Lésourd M, Artigas F. Br J Pharmacol; 1997 Oct; 122(4):733-41. PubMed ID: 9375971 [Abstract] [Full Text] [Related]
5. Selective 5-HT1A receptor agonist, 8-OH-DPAT, locally administered into the dorsal raphe nucleus increased extracellular acetylcholine concentrations in the medial prefrontal cortex of conscious rats. Katsu H. Nihon Shinkei Seishin Yakurigaku Zasshi; 2001 Oct; 21(4):121-3. PubMed ID: 11769569 [Abstract] [Full Text] [Related]
6. Effect of a serotonin depleting regimen of 3,4-methylenedioxymethamphetamine (MDMA) on the subsequent stimulation of acetylcholine release in the rat prefrontal cortex. Nair SG, Gudelsky GA. Brain Res Bull; 2006 Apr 28; 69(4):382-7. PubMed ID: 16624669 [Abstract] [Full Text] [Related]
7. Changes in 5-HT1A receptor binding and G-protein activation in the rat brain after estrogen treatment: comparison with tamoxifen and raloxifene. Le Saux M, Di Paolo T. J Psychiatry Neurosci; 2005 Mar 28; 30(2):110-7. PubMed ID: 15798786 [Abstract] [Full Text] [Related]
8. In-vivo effects of the 1,2,4-piperazine derivatives MM5 and MC1, putative 5-HT agonists, on dopamine and serotonin release in rat prefrontal cortex. Iskra-Jopa J, Gołembiowska K, Dziubina A, Cybulski M, Duszyńska B, Chilmonczyk Z. J Pharm Pharmacol; 2005 Feb 28; 57(2):205-11. PubMed ID: 15720784 [Abstract] [Full Text] [Related]
9. Pharmacological characterization of LY293284: A 5-HT1A receptor agonist with high potency and selectivity. Foreman MM, Fuller RW, Rasmussen K, Nelson DL, Calligaro DO, Zhang L, Barrett JE, Booher RN, Paget CJ, Flaugh ME. J Pharmacol Exp Ther; 1994 Sep 28; 270(3):1270-81. PubMed ID: 7523657 [Abstract] [Full Text] [Related]
10. Alterations in 8-hydroxy-2-(dipropylamino)tetralin-induced neuroendocrine responses after 5,7-dihydroxytryptamine-induced denervation of serotonergic neurons. Van de Kar LD, Li Q, Cabrera TM, Brownfield MS, Battaglia G. J Pharmacol Exp Ther; 1998 Jul 28; 286(1):256-62. PubMed ID: 9655867 [Abstract] [Full Text] [Related]
11. 8-OH-DPAT-induced effects on prepulse inhibition: pre- vs. post-synaptic 5-HT1A receptor activation. Gogos A, Kusljic S, van den Buuse M. Pharmacol Biochem Behav; 2005 Jul 28; 81(3):664-72. PubMed ID: 15955549 [Abstract] [Full Text] [Related]
12. Cellular and behavioral effects of 5-HT1A receptor agonist 8-OH-DPAT in a rat model of levodopa-induced motor complications. Ba M, Kong M, Ma G, Yang H, Lu G, Chen S, Liu Z. Brain Res; 2007 Jan 05; 1127(1):177-84. PubMed ID: 17113046 [Abstract] [Full Text] [Related]
13. F15063, a potential antipsychotic with dopamine D(2)/D(3) receptor antagonist and 5-HT(1A) receptor agonist properties: influence on immediate-early gene expression in rat prefrontal cortex and striatum. Bruins Slot LA, Lestienne F, Grevoz-Barret C, Newman-Tancredi A, Cussac D. Eur J Pharmacol; 2009 Oct 12; 620(1-3):27-35. PubMed ID: 19695244 [Abstract] [Full Text] [Related]
14. Differential induction of 5-HT1A-mediated responses in vivo by three chemically dissimilar 5-HT1A agonists. Scott PA, Chou JM, Tang H, Frazer A. J Pharmacol Exp Ther; 1994 Jul 12; 270(1):198-208. PubMed ID: 8035316 [Abstract] [Full Text] [Related]
15. Analysis of the 5-HT1A receptor involvement in passive avoidance in the rat. Misane I, Johansson C, Ogren SO. Br J Pharmacol; 1998 Oct 12; 125(3):499-509. PubMed ID: 9806333 [Abstract] [Full Text] [Related]
16. 5-HT1A receptors and the tail-flick response. IV. Spinally localized 5-HT1A receptors postsynaptic to serotoninergic neurones mediate spontaneous tail-flicks in the rat. Bervoets K, Rivet JM, Millan MJ. J Pharmacol Exp Ther; 1993 Jan 12; 264(1):95-104. PubMed ID: 8423555 [Abstract] [Full Text] [Related]
17. Nelumbinis Semen reverses a decrease in 5-HT1A receptor binding induced by chronic mild stress, a depression-like symptom. Jang CG, Kang M, Cho JH, Lee SB, Kim H, Park S, Lee J, Park SK, Hong M, Shin MK, Shim IS, Bae H. Arch Pharm Res; 2004 Oct 12; 27(10):1065-72. PubMed ID: 15554266 [Abstract] [Full Text] [Related]
18. Effects of chronic treatment with escitalopram or citalopram on extracellular 5-HT in the prefrontal cortex of rats: role of 5-HT1A receptors. Ceglia I, Acconcia S, Fracasso C, Colovic M, Caccia S, Invernizzi RW. Br J Pharmacol; 2004 Jun 12; 142(3):469-78. PubMed ID: 15148253 [Abstract] [Full Text] [Related]
19. Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist. De Vry J, Schohe-Loop R, Heine HG, Greuel JM, Mauler F, Schmidt B, Sommermeyer H, Glaser T. J Pharmacol Exp Ther; 1998 Mar 12; 284(3):1082-94. PubMed ID: 9495870 [Abstract] [Full Text] [Related]
20. Single-unit responses of serotonergic dorsal raphe neurons to 5-HT1A agonist and antagonist drug administration in behaving cats. Fornal CA, Litto WJ, Metzler CW, Marrosu F, Tada K, Jacobs BL. J Pharmacol Exp Ther; 1994 Sep 12; 270(3):1345-58. PubMed ID: 7932189 [Abstract] [Full Text] [Related] Page: [Next] [New Search]